GLPwatch
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
NCT01817569 · Completed
Last updated 2026-05-28This clinical trial studied the long-term safety of the diabetes medication exenatide (Byetta) in people with type 2 diabetes.
Status Completed The study has finished.
Type Observational
Participants 2,948 people
Who can join all sexes
Timeline Started 2011-02 · est. completion 2019-10
Where 46 sites · Japan
What this study is testing ClinicalTrials.gov NCT01817569 ↗
Description as written by the study sponsor.
The purpose of this investigation is to describe general safety profile of type II Diabetes Mellitus (DM) Japanese patients under exenatide therapy in real world medical practices
| Main thing measured | Adverse event incidence. |
|---|---|
| Sponsor | AstraZeneca |
| Conditions studied | Type 2 Diabetes |
| GLP-1 drugs | exenatide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01817569 ↗